RegenxBio completes venture financing

RegenxBio Inc., Washington, D.C. Business: Gene/Cell therapy Date completed: 2015-01-21 Type: Venture financing Raised: $30 million Investors: Venrock; Brookside Capital; Deerfield Management; Fidelit...